Phosphorylation of serine 305 in tau inhibits aggregation.


Journal

Neuroscience letters
ISSN: 1872-7972
Titre abrégé: Neurosci Lett
Pays: Ireland
ID NLM: 7600130

Informations de publication

Date de publication:
23 01 2019
Historique:
received: 20 08 2018
revised: 30 10 2018
accepted: 06 11 2018
pubmed: 14 11 2018
medline: 22 6 2019
entrez: 14 11 2018
Statut: ppublish

Résumé

Alzheimer's disease and other tauopathies are characterized by the brain accumulation of hyperphosphorylated aggregated tau protein forming pathological inclusions. Although elevated tau phosphorylated at many amino acid residues is a hallmark of pathological tau, some evidence suggest that tau phosphorylation at unique sites, especially within its microtubule-binding domain, might inhibit aggregation. In this study, the effects of phosphorylation of two unique residues within this domain, serine 305 (S305) and serine 320 (S320), were examined in the context of established aggregation and seeding models. It was found that the S305E phosphomimetic significantly inhibited both tau seeding and tau aggregation in this model, while S320E did not. To further explore S305 phosphorylation in vivo, a monoclonal antibody (2G2) specific for tau phosphorylated at S305 was generated and characterized. Consistent with inhibition of tau aggregation, phosphorylation of S305 was not detected in pathological tau inclusions in Alzheimer's disease brain tissue. This study indicates that phosphorylation of unique tau residues can be inhibitory to aggregate formation, and has important implications for potential kinase therapies. Additionally, it creates new tools for observing these changes in vivo.

Identifiants

pubmed: 30423399
pii: S0304-3940(18)30774-2
doi: 10.1016/j.neulet.2018.11.011
pmc: PMC6351168
mid: NIHMS1512962
pii:
doi:

Substances chimiques

Antibodies, Monoclonal 0
MAPT protein, human 0
tau Proteins 0
Serine 452VLY9402

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

187-192

Subventions

Organisme : NINDS NIH HHS
ID : L30 NS089022
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG047266
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS089622
Pays : United States
Organisme : NINDS NIH HHS
ID : T32 NS082168
Pays : United States

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Références

Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6923-8
pubmed: 11381127
FEBS Lett. 1989 Jul 3;250(2):596-600
pubmed: 2546812
J Biol Chem. 2018 Feb 16;293(7):2408-2421
pubmed: 29259137
J Mol Biol. 1977 Oct 25;116(2):227-47
pubmed: 146092
Biochemistry. 2012 Feb 21;51(7):1396-406
pubmed: 22304362
J Neurosci. 2011 May 25;31(21):7604-18
pubmed: 21613474
Nat Commun. 2011;2:252
pubmed: 21427723
Biochim Biophys Acta. 2005 Jan 3;1739(2-3):158-66
pubmed: 15615635
J Biol Chem. 2008 Nov 14;283(46):32066-76
pubmed: 18725412
Acta Neuropathol Commun. 2017 Jul 31;5(1):58
pubmed: 28760159
Biochemistry. 1999 Mar 23;38(12):3549-58
pubmed: 10090741
Acta Neuropathol. 2017 May;133(5):665-704
pubmed: 28386764
Mol Biol Cell. 1992 Oct;3(10):1141-54
pubmed: 1421571
Nature. 2017 Jul 13;547(7662):185-190
pubmed: 28678775
Proc Natl Acad Sci U S A. 2000 May 9;97(10):5129-34
pubmed: 10805776
Biochemistry. 2012 Oct 30;51(43):8597-607
pubmed: 23043292
Biol Psychiatry. 2018 Feb 15;83(4):337-346
pubmed: 28506438
J Biol Chem. 2007 Aug 10;282(32):23645-54
pubmed: 17562708
Front Neurol. 2013 Jul 01;4:83
pubmed: 23847585
Trends Mol Med. 2009 Mar;15(3):112-9
pubmed: 19246243
Neuron. 2010 Sep 23;67(6):953-66
pubmed: 20869593
Brain. 2017 Feb;140(2):266-278
pubmed: 27658420
Mol Neurodegener. 2008 Jul 10;3:8
pubmed: 18616804
J Neurochem. 2003 Sep;86(6):1359-68
pubmed: 12950445
Nat Rev Neurosci. 2016 Jan;17(1):5-21
pubmed: 26631930
Neuroreport. 1999 Feb 25;10(3):497-501
pubmed: 10208578
PLoS One. 2018 Apr 2;13(4):e0195211
pubmed: 29608591
FEBS Lett. 1999 Jan 25;443(2):93-6
pubmed: 9989582
Proc Natl Acad Sci U S A. 1988 Jun;85(12):4506-10
pubmed: 3132715
J Neurosci Res. 2015 Oct;93(10):1567-80
pubmed: 26123245
Biochemistry. 2013 Dec 17;52(50):9068-79
pubmed: 24251416
PLoS Biol. 2009 Feb 17;7(2):e34
pubmed: 19226187
Proc Natl Acad Sci U S A. 1986 Jul;83(13):4913-7
pubmed: 3088567
Science. 2003 Apr 25;300(5619):636-40
pubmed: 12714745
J Biol Chem. 2011 Apr 29;286(17):15317-31
pubmed: 21372138
J Biol Chem. 1997 Dec 26;272(52):33118-24
pubmed: 9407097
FEBS Lett. 2007 Jun 12;581(14):2657-62
pubmed: 17512525
Ann Neurol. 2002 Mar;51(3):373-6
pubmed: 11891833
Biochemistry. 2006 Feb 21;45(7):2283-93
pubmed: 16475817
Biomolecules. 2016 Jan 06;6(1):6
pubmed: 26751493
J Phys Chem B. 2015 Apr 2;119(13):4582-93
pubmed: 25775228
Nature. 1996 Oct 10;383(6600):550-3
pubmed: 8849730

Auteurs

Kevin H Strang (KH)

Department of Neuroscience, University of Florida, Gainesville, FL 32610, USA; Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL 32610, USA.

Zachary A Sorrentino (ZA)

Department of Neuroscience, University of Florida, Gainesville, FL 32610, USA; Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL 32610, USA.

Cara J Riffe (CJ)

Department of Neuroscience, University of Florida, Gainesville, FL 32610, USA; Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL 32610, USA.

Kimberly-Marie M Gorion (KM)

Department of Neuroscience, University of Florida, Gainesville, FL 32610, USA; Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL 32610, USA.

Niran Vijayaraghavan (N)

Department of Neuroscience, University of Florida, Gainesville, FL 32610, USA; Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL 32610, USA.

Todd E Golde (TE)

Department of Neuroscience, University of Florida, Gainesville, FL 32610, USA; Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL 32610, USA; McKnight Brain Institute, University of Florida, Gainesville, FL 32610, USA.

Benoit I Giasson (BI)

Department of Neuroscience, University of Florida, Gainesville, FL 32610, USA; Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL 32610, USA; McKnight Brain Institute, University of Florida, Gainesville, FL 32610, USA. Electronic address: bgiasson@ufl.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH